EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 67 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 683 Capital Management, LLC | 3,750,000 | $2,640,000 | 0.19% |
| Simplify Asset Management Inc. | 1,099,653 | $774,156 | 0.10% |
| GSA CAPITAL PARTNERS LLP | 285,677 | $201 | 0.02% |
| RBF Capital, LLC | 391,265 | $275,451 | 0.02% |
| Y-Intercept (Hong Kong) Ltd | 161,230 | $113,506 | 0.01% |
| UBS OCONNOR LLC | 393,975 | $277,358 | 0.01% |
| Annandale Capital, LLC | 36,700 | $26 | 0.01% |
| XTX Topco Ltd | 56,272 | $39,615 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 206,700 | $145,517 | 0.00% |
| Sigma Planning Corp | 101,500 | $71,456 | 0.00% |
| AMERIPRISE FINANCIAL INC | 8,592,471 | $6,049,099 | 0.00% |
| DRW Securities, LLC | 120,365 | $85 | 0.00% |
| DFPG INVESTMENTS, LLC | 32,430 | $26,884 | 0.00% |
| Ergoteles LLC | 41,400 | $29,146 | 0.00% |
| Sequoia Financial Advisors, LLC | 63,000 | $44,352 | 0.00% |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 51,075 | $35,957 | 0.00% |
| DAVENPORT & Co LLC | 208,701 | $146,926 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 206,113 | $145 | 0.00% |
| Weiss Multi-Strategy Advisers LLC | 48,894 | $34 | 0.00% |
| Verition Fund Management LLC | 150,000 | $105,600 | 0.00% |
External links
This page lists EIGER BIOPHARMACEUTICALS INC's shareholders in Q2 2023. To view EIGER BIOPHARMACEUTICALS INC's shareholder history, click here.